• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Comparison of the ability to control anemia in patients on hemodialysis and peritoneal dialysis considering iron reserves and plasma erythropoietin].

作者信息

Majdan M, Ksiazek A, Spasiewicz D

机构信息

Kliniki Nefrologii Akademii Medycznej w Lublirtie.

出版信息

Pol Arch Med Wewn. 1996 Apr;95(4):307-12.

PMID:8755836
Abstract

It is known, that patients undergoing CAPD have less severe anaemia than those receiving hemodialysis (HD). In addition they require smaller doses of rHuEpo to control anaemia than HD pts. We have decided to compare plasma erythropoietin (pEpo) and iron reserves (IR) in these both groups of pts. 17 pts on CAPD and 50 pts on HD were diagnosed. 35% pts on CAPD and 52% pts on HD required permanent rHuEpo treatment to maintain hemoglobin (Hb) concentration above 9.5g/dl and Ht above 30%. Plasma EPO and ferritin levels were measured by enzymatic immunoassay. IR were estimated by formula: IR = 400x [ln (ferritin) - ln(50)]. Compared to CAPD, HD pts had higher IR (405 +/- 76 vs. 358 +/- 120 mg) but differences are not statistically significant. Plasma Epo level (geom. mean) was statistically significant higher p = 0.025 in HD pts compared to CAPD pts (8.68, range 2-53 vs. 5.21 range 2-15 mV/ml) Hb concentrations did not differ significantly between pts on CAPD and HD. CAPD pts controlled anaemia better than HD pts despite lower concentration of endogenous erythropoietin.

摘要

相似文献

1
[Comparison of the ability to control anemia in patients on hemodialysis and peritoneal dialysis considering iron reserves and plasma erythropoietin].
Pol Arch Med Wewn. 1996 Apr;95(4):307-12.
2
Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.
Int Urol Nephrol. 2001;33(3):541-6. doi: 10.1023/a:1019558511411.
3
Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.与血液透析患者相比,腹膜透析患者对促红细胞生成素的反应改善:缺铁的作用。
Adv Perit Dial. 1994;10:135-8.
4
Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.接受血液透析和持续性非卧床腹膜透析的儿童的重组人促红细胞生成素剂量
Pediatr Nephrol. 1997 Oct;11(5):628-30. doi: 10.1007/s004670050352.
5
Comparison of plasma erythropoietin concentrations and iron status in hemodialyzed patients not requiring and requiring rHuEpo therapy.
Nephron. 1996;73(3):425-9. doi: 10.1159/000189105.
6
Does parathyroid hormone affect erythropoietin therapy in dialysis patients?甲状旁腺激素对透析患者的促红细胞生成素治疗有影响吗?
Med Princ Pract. 2007;16(1):63-7. doi: 10.1159/000096143.
7
Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.接受血液透析或腹膜透析治疗的终末期肾病患者血液中镁和锌水平的比较。
Magnes Res. 2002 Dec;15(3-4):229-36.
8
[Clinical analysis of CAPD-treated patients without anemia].[未患贫血的持续性非卧床腹膜透析治疗患者的临床分析]
Wiad Lek. 2003;56(1-2):14-8.
9
Plasma erythropoietin level and iron reserves in haemodialysis patients with and without acquired cystic kidney disease.
Int Urol Nephrol. 1997;29(1):113-8. doi: 10.1007/BF02551426.
10
Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Perit Dial Int. 1993;13 Suppl 2:S541-3.